Search Results - "Wajs, E."

Efficacy and safety of canagliflozin in subjects with type 2 diabetes and chronic kidney disease by Yale, J.-F., Bakris, G., Cariou, B., Yue, D., David-Neto, E., Xi, L., Figueroa, K., Wajs, E., Usiskin, K., Meininger, G.

“…Aims Canagliflozin is a sodium glucose co‐transporter 2 inhibitor in development for treatment of type 2 diabetes mellitus (T2DM). This study evaluated the…”
Get full text

Efficacy and safety of canagliflozin over 52 weeks in patients with type 2 diabetes mellitus and chronic kidney disease by Yale, J.-F., Bakris, G., Cariou, B., Nieto, J., David-Neto, E., Yue, D., Wajs, E., Figueroa, K., Jiang, J., Law, G., Usiskin, K., Meininger, G.

“…Aim This study evaluated the efficacy and safety of canagliflozin, a sodium glucose co‐transporter 2 inhibitor, in patients with type 2 diabetes mellitus…”
Get full text

Inversion of flow and heat transfer of the paramagnetic fluid in a differentially heated cube by Kenjereš, S., Fornalik-Wajs, E., Wrobel, W., Szmyd, J.S.

“…•We performed combined experimental and numerical studies of flow and heat transfer reorganization of a paramagnetic fluid by imposed magnetization force.•We…”
Get full text

Experimental and numerical analysis of thermo-magnetic convection in a vertical annular enclosure by Wrobel, W., Fornalik-Wajs, E., Szmyd, J.S.

“…In the present paper an experimental and numerical analysis of a thermo-magnetic convective flow of paramagnetic fluid in an annular enclosure with a round rod…”
Get full text

A placebo‐controlled trial of the 5‐HT1A agonist R‐137696 on symptoms, visceral hypersensitivity and on impaired accommodation in functional dyspepsia by Tack, J., Van Den Elzen, B., Tytgat, G., Wajs, E., Van Nueten, L., De Ridder, F., Boeckxstaens, G.

“…Acute studies suggested a therapeutic benefit for fundus‐relaxing drugs in functional dyspepsia (FD) with visceral hypersensitivity (VH) to gastric distention…”
Get full text

Numerical and Experimental Study of Rayleigh–Bénard–Kelvin Convection by Kenjereš, S., Pyrda, L., Fornalik-Wajs, E., Szmyd, J. S.

“…We performed experimental and numerical studies of combined effects of thermal buoyancy and magnetization force applied on a cubical enclosure of a…”
Get full text

Reproducibility and symptomatic predictors of a slow nutrient drinking test in health and in functional dyspepsia by Kindt, S., Coulie, B., Wajs, E., Janssens, J., Tack, J.

“…Impaired accommodation to a meal has been recognized as a pathophysiological mechanism in functional dyspepsia (FD). Based on observations in tertiary care…”
Get full text

The influence of the novel 5‐HT1A agonist R137696 on the proximal stomach function in healthy volunteers by Boeckxstaens, G. E., Tytgat, G. N., Wajs, E., Van Nueten, L., De Ridder, F., Meulemans, A., Tack, J.

“…As fundic dysaccommodation represents one of the pathophysiological mechanisms underlying functional dyspepsia, gastric relaxant agents may serve as a new…”
Get full text

The WC-Co electrospark alloying coatings modified by laser treatment by Radek, N., Wajs, E., Luchka, M.

“…The paper analyzes the effect of the laser treatment process on the properties of electrospark alloying coatings. The properties are assessed after laser…”
Get full text

Oscillatory states in thermal convection of a paramagnetic fluid in a cubical enclosure subjected to a magnetic field gradient by Kenjereš, S, Pyrda, L, Wrobel, W, Fornalik-Wajs, E, Szmyd, J S

“…We report experimental and numerical studies of combined natural and magnetic convection of a paramagnetic fluid inside a cubical enclosure heated from below…”
Get full text

Improvement of the Performance Parameters of Precision Friction Couples in the Magnetic Field by Svirid, M. N., Wajs, E., Primak, L. B., Borodii, V. N., Yakobchuk, A. E.

“…The paper considers the possibility to control the restoration and wear processes during friction depending on the location of magnetic poles using…”
Get full text

The 5‐HT4 antagonist R216073 does not affect gastric motor and sensory function in patients with functional dyspepsia by VAN LELYVELD, N., TER LINDE, J., BARON, A., MUNDT, M., WAJS, E., SAMSOM, M.

“…Summary Background  Serotonin and the 5‐HT4 receptor play an important role in gastrointestinal motor and sensory functions. While 5‐HT4 agonists are known for…”
Get full text

P304 Efficacité et tolérance de la canagliflozine sur une période de 52 semaines chez des patients diabétiques de type 2 présentant une insuffisance rénale chronique by Nieto, J, Yale, J, Bakris, G, Cariou, B, Wajs, E, Figueroa, K, Jiang, J, Ricci, L, Usiskin, K, Meininger, G

“…Introduction Cette étude randomisée en double aveugle a évalué l’efficacité et la tolérance de la canagliflozine (CANA), sur 52 semaines chez des patients DT2…”
Get full text

P.006 Cardiac safety of esketamine nasal spray in treatment-resistant depression: Results from the clinical development program by Doherty, T., Wajs, E., Funck-Brentano, C., Weber A., M., Miller, J., Singh B., J.

Get full text

Melatonin affects proopiomelanocortin gene expression in the immune organs of the rat by Wajs, E, Kutoh, E, Gupta, D

“…The induction of opioid peptides derived from cells of the immune system is postulated to be the main mechanism involved in the immunomodulatory role of…”
Get more information

P.033 Managing esketamine treatment frequency toward successful outcomes: Analysis of phase 3 data by Nijs, M., Wajs, E., Aluisio, L., Daly J., E., Janik, A., Borentain, S., Singh B., J., Wiegand, F., DiBernardo, A.

Get full text

P.034 Factor analysis of the MADRS over the course of treatment in patients with treatment-resistant depression by Borentain, S., Gogate, J., Turkoz, I., Jamieson, C., Fombu, E., Cabrera, P., Périco, C.A.M., Popova, V., Wajs, E., Daly, E.J., Singh, J.B., DiBernardo, A.

Get full text

P.327 Withdrawal symptom assessment in an esketamine safety study in patients with treatment-resistant depression by Aluisio, L., Wajs, E., DiBernardo, A., Chen, N., Drevets, W., Daly, E., Zannikos, P., Curran, V., Krystal, A., Chen, G., Lane, R., Singh, J.

Get full text

P.038 Effect of esketamine nasal spray on cognition in patients with treatment-resistant depression: results from five phase-3 studies by Morrison, R., Singh, J., Daly, E., Fedgchin, M., Wajs, E., Alusio, L., Ochs-Ross, R., Popova, V., Karcher, K., Lane, R., Lim, P., Cooper, K., Maruff, P., Hough, D., Drevets, W., Manji, H.

Get full text

Long-term safety of esketamine nasal spray plus oral antidepressant in patients with treatment-resistant depression: SUSTAIN-2 phase 3 study by Wajs, E., Leah, A., Morrison, R., Daly, E., Lane, R., Lim, P., Holder, R., Sanacora, G., Young, A.H., Kasper, S., Sulaiman, A.H., Li, C.T., Paik, J.W., Manji, H., Hough, D., Drevets, W., Singh, J.

Get full text